Fusaric Acid
A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
Also Known As:
5-Butyl-2-pyridinedicarboxylic Acid; Calcium Fusarate; 5 Butyl 2 pyridinedicarboxylic Acid; Acid, 5-Butyl-2-pyridinedicarboxylic; Acid, Fusaric; Fusarate, Calcium; 2-Pyridinecarboxylic acid, 5-butyl-
Networked: 58
relevant articles (1 outcomes,
3 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Chuturgoon, Anil A:
5 articles
(01/2021 - 09/2016)
|
2. | Nagiah, Savania:
5 articles
(01/2021 - 09/2016)
|
3. | Stack, Brendan C:
5 articles
(06/2014 - 07/2004)
|
4. | Guo, Shiwei:
4 articles
(10/2021 - 11/2012)
|
5. | Shen, Qirong:
4 articles
(10/2021 - 11/2012)
|
6. | Wang, Min:
3 articles
(10/2021 - 11/2012)
|
7. | Ghazi, Terisha:
3 articles
(01/2021 - 11/2017)
|
8. | Sun, Yuming:
2 articles
(10/2021 - 09/2016)
|
9. | Sheik Abdul, Naeem:
2 articles
(11/2017 - 09/2016)
|
10. | Dong, Xian:
2 articles
(04/2014 - 11/2012)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures